Rs 109.9 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Glimestar M2 Tablet combines Glimepiride and Metformin to manage type 2 diabetes mellitus when diet, exercise, and monotherapy are insufficient. Glimepiride stimulates the pancreas to release more insulin, while Metformin reduces glucose production in the liver and improves the body's sensitivity to insulin. This combination helps to maintain better control of blood sugar levels. The tablet is usually taken once daily with a meal to reduce gastrointestinal side effects. Common side effects include nausea, diarrhea, stomach pain, and loss of appetite. It is essential to follow a healthcare provider's instructions regarding dosage and to monitor blood sugar levels regularly. This medication is not suitable for people with severe kidney or liver disease, type 1 diabetes, or those who are pregnant or breastfeeding. Regular follow-up and adherence to the prescribed treatment plan are crucial for effective diabetes management.
Active Ingredients: Contains Glimepiride 2 mg and Metformin 500 mg. Benefits: Manages type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate glycemic control. Usage: Taken orally once daily with a meal, as prescribed by a physician. Mechanism: Glimepiride increases insulin secretion from the pancreas, while Metformin reduces glucose production in the liver and enhances insulin sensitivity. Safety: Not recommended for individuals with severe kidney or liver disease, type 1 diabetes, or during pregnancy and breastfeeding; consult a doctor before use.
GLIMESTAR M2 TABLET helps manage blood glucose levels. Glimepiride boosts insulin secretion from the pancreas to reduce blood sugar, while Metformin decreases glucose production in the liver, slows glucose absorption in the intestines, and enhances the body's insulin sensitivity.
Take GLIMESTAR M2 TABLET exactly as prescribed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition. Do not discontinue the medication without consulting your doctor.
PREGNANCY CONTRAINDICATED:GLIMESTAR M2 TABLET should not be used during pregnancy. Consult your doctor if you are planning to become pregnant. BREASTFEEDING CONTRAINDICATED:GLIMESTAR M2 TABLET should not be used while breastfeeding as it may pass into breast milk. Seek advice from your doctor before taking this medication. DRIVING AND USING MACHINES USE WITH CAUTION:Avoid driving or operating machinery if you experience symptoms of low or high blood sugar (such as dizziness, tiredness, or trembling) or if you notice vision changes due to fluctuating blood sugar levels. ALCOHOL CONSULT YOUR DOCTOR:Refrain from drinking alcohol while taking GLIMESTAR M2 TABLET, as it may alter the medication’s effect on blood sugar levels and increase the risk of lactic acidosis. Consult your doctor for guidance. KIDNEY CONSULT YOUR DOCTOR:GLIMESTAR M2 TABLET is not recommended for individuals with severe kidney disease. It should be used with caution in those with other kidney conditions, and your dose may need adjustment based on kidney function. Consult your doctor before use. LIVER CONSULT YOUR DOCTOR:This medication is not recommended for those with severe liver disease and should be used with caution in patients with liver issues. Your dose may be adjusted based on liver function. Consult your doctor before use. ALLERGY CONTRAINDICATED:Do not take GLIMESTAR M2 TABLET if you are allergic to Glimepiride, Metformin, or other sulfonylureas (like glipizide or glibenclamide) or sulfonamides (such as sulfamethoxazole). HEART DISEASE CONTRAINDICATED:GLIMESTAR M2 TABLET is not recommended for patients with acute heart conditions, recent heart attacks, severe circulatory issues, or breathing difficulties indicative of heart failure. Consult your doctor before use. USE IN PEDIATRICS CONTRAINDICATED:GLIMESTAR M2 TABLET is generally not recommended for children and adolescents under 18 years of age. Consult a pediatrician for advice. USE IN GERIATRICS CONSULT YOUR DOCTOR:The use of GLIMESTAR M2 TABLET in elderly patients (aged 75 years or older) is not recommended and should be approached with caution in those aged 65 years or older, especially with impaired kidney function. Your doctor may need to monitor your kidney function more closely during treatment. Consult your doctor before use.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s